Gilead Sciences GILD
US equityMarket cap rank #82Drug Manufacturers - GeneralCAR-T TherapyInfectious DiseaseCancer Research
$166.89 −$0.68 (-0.41%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $166.89 0.00%
Open$164.11
Prev close$167.57
Day range$164.00 – $169.06
Volume5.82M
Market cap$207.00B
P/E (TTM)–
Dividend yield1.95%
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Institutional ownership90.9%-0.25 pts vs. prior quarter
Institutions holding2,769+52 vs. prior quarter
Insider trades (recent)17 buys / 33 sellsNet selling
Short interest1.63% of floatDays to cover 3.7 · as of 15 Oct 2026
Short-sale volume share15.3%5-day average of daily volume
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$59.76M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 1.96% to 1.63% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Swedbank Robur Fonder AB | Mutual Fund | 2026/Q3 | +971,977 | 0.2% |
| SG Americas Securities, LLC | Private Company | 2026/Q3 | +3,812,458 | 0.4% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +3,794,340 | 2.4% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +2,965,114 | 0.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,833,135 | 9.8% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +2,093,870 | 0.2% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +1,775,452 | 0.2% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +1,762,836 | 0.5% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +1,617,017 | 0.1% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +1,574,202 | 0.3% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,428,877 | 0.1% |
| Bessemer Investment Management LLC | Mutual Fund | 2026/Q3 | +1,379,838 | 0.1% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,357,967 | 4.9% |
| Westfield Capital Management Company, L.P. | Mutual Fund | 2026/Q3 | +1,260,939 | 0.1% |
| Jupiter Fund Management Plc | Mutual Fund | 2026/Q3 | +1,153,388 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Andrew Dickinson | Chief Financial Officer | Automatic Disposition | -3,000 | $156.22 | 161,096 |
| 14 Oct 2026 | Andrew Dickinson | Chief Financial Officer | Intent to Sell (Form 144) | -3,000 | $156.22 | – |
| 14 Oct 2026 | Johanna Mercier | Chief Commercial & Corporate Affairs Officer | Automatic Disposition | -3,000 | $156.22 | 113,684 |
| 14 Oct 2026 | Johanna Mercier | Chief Commercial & Corporate Affairs Officer | Intent to Sell (Form 144) | -3,000 | $156.22 | – |
| 30 Sep 2026 | Daniel Patrick O'Day | Chairperson & CEO | Automatic Disposition | -15,000 | $148.63 | 566,683 |
| 21 Sep 2026 | Erin Burkhart | Chief Accounting Officer | Derivative Exercise and Sale | -768 | $152.67 | 1,455 |
| 21 Sep 2026 | Erin Burkhart | Chief Accounting Officer | Derivative Exercise and Retained | +1,455 | – | 1,455 |
| 14 Sep 2026 | Andrew Dickinson | Chief Financial Officer | Automatic Disposition | -3,000 | $145.29 | 164,096 |
| 14 Sep 2026 | Johanna Mercier | Chief Commercial & Corporate Affairs Officer | Automatic Disposition | -3,000 | $145.29 | 116,684 |
| 9 Sep 2026 | Andrew Dickinson | Chief Financial Officer | Derivative Exercise and Sale | -1,347 | $144.81 | 167,096 |
| 9 Sep 2026 | Andrew Dickinson | Chief Financial Officer | Derivative Exercise and Retained | +1,450 | – | 167,096 |
| 9 Sep 2026 | Daniel Patrick O'Day | Chairperson & CEO | Derivative Exercise and Sale | -4,230 | $144.81 | 581,683 |
| 9 Sep 2026 | Daniel Patrick O'Day | Chairperson & CEO | Derivative Exercise and Retained | +4,550 | – | 581,683 |
| 9 Sep 2026 | Johanna Mercier | Chief Commercial & Corporate Affairs Officer | Derivative Exercise and Sale | -1,347 | $144.81 | 119,684 |
| 9 Sep 2026 | Johanna Mercier | Chief Commercial & Corporate Affairs Officer | Derivative Exercise and Retained | +1,450 | – | 119,684 |
| 9 Sep 2026 | Dietmar Berger | Chief Medical Officer | Derivative Exercise and Sale | -263 | $144.81 | 19,522 |
| 9 Sep 2026 | Dietmar Berger | Chief Medical Officer | Derivative Exercise and Retained | +270 | – | 19,522 |
| 9 Sep 2026 | Keeley M. Wettan | Executive VP, General Counsel of Legal & Compliance and Secretary | Derivative Exercise and Sale | -285 | $144.81 | 8,759 |
| 9 Sep 2026 | Keeley M. Wettan | Executive VP, General Counsel of Legal & Compliance and Secretary | Derivative Exercise and Retained | +305 | – | 8,759 |
| 31 Aug 2026 | Daniel Patrick O'Day | Chairperson & CEO | Automatic Disposition | -15,000 | $149.38 | 577,133 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 20,270,007 | 1.6% | 3.7 |
| 30 Sep 2026 | 21,828,725 | 1.8% | 3.4 |
| 15 Sep 2026 | 18,304,875 | 1.5% | 3.7 |
| 31 Aug 2026 | 23,007,029 | 1.9% | 4.2 |
| 14 Aug 2026 | 23,183,970 | 1.9% | 3.2 |
| 31 Jul 2026 | 24,385,621 | 2.0% | 3.9 |
No comments yet — be the first to weigh in on GILD.
Sign in to join the discussion.